The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.
Preventing blood-borne viruses in prison settings: ECDC and EMCDDA Guidance
In their joint public health guidance published today at AIDS 2018, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) outline evidence-based and effective measures to help prevent and control the transmission of blood-borne viruses in prison settings.
ECDC and EMCDDA make the case for active case finding of communicable diseases in prison
In their joint public health Guidance published today, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), present the evidence on active case finding as a key measure to diagnose communicable diseases early.
1 in 2 people living with HIV in Europe is diagnosed late: ECDC and WHO urge improvement in testing practices
The WHO European Region is the only Region worldwide where the number of new HIV infections is rising. With more than 160 000 people newly diagnosed with HIV across the Region, including more than 29 000 new cases from the European Union and European Economic Area (EU/EEA), this trend continued in 2016.
ECDC-EMCDDA review: Can active case finding help reduce communicable diseases in prisons?
ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) have systematically retrieved and assessed evidence on active case findings for blood-borne viruses like HIV, hepatitis B and C, sexually transmitted infections as well as tuberculosis in prison settings in the EU/EEA.
Because it’s best to know: start of European HIV-Hepatitis testing week
An estimated 122 000 people living with HIV across Europe are not aware of their HIV infection and a large number out of the estimated 9 million Europeans that are affected by chronic hepatitis B or C have not yet been tested or diagnosed. ECDC welcomes the efforts of European HIV-Hepatitis Testing Week which starts today.
ECDC study: nearly one in six new HIV diagnoses in Europe are among people over 50
A study published in The Lancet HIV today showed that while the rate of newly reported HIV cases in Europe remained steady in younger people between 2004 and 2015, it increased by 2% each year overall in older people. With around 30 000 newly diagnosed HIV infections reported each year over the last decade, the HIV epidemic remains a significant public health problem in the 31 countries of the European Union and European Economic Area (EU/EEA),
The continuum of HIV care: how is Europe doing?
The continuum of HIV care is a framework that enables countries to monitor the effectiveness of their HIV response - from diagnosis towards viral suppression (which means that the virus is no longer detectable in the blood). This report provides a snapshot of the status of the continuum of care for the whole region as well as each of the 48 countries reporting at least some continuum data.
Reversing the HIV epidemic: Europe needs to scale-up prevention, testing and treatment
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union Conference and ECDC , HIV experts from across the European Union discussed how to reverse the HIV epidemic and how to prepare Europe to achieve the set target of ending AIDS by 2030.
1 in 7 people living with HIV in the EU/EEA are not aware of their HIV status
Almost 30 000 newly diagnosed HIV infections were reported by the 31 European Union and European Economic Area (EU/EEA) countries in 2015, according to data published today by ECDC and the WHO Regional Office for Europe.